Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

May 24, 2018

Doctors Without Borders/Médecins Sans Frontières (MSF) made the following statement after the adoption of a resolution on “Addressing the burden of snakebite envenoming” during the 71st World Health Assembly today.

May 22, 2018

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the launch of the Global Research & Development (R&D) collaboration hub on antimicrobial resistance (AMR) announced at the World Health Assembly today.

May 11, 2018

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) made the following statement today in response to President Trump’s speech on drug pricing.

April 27, 2018

The Office of the United States Trade Representative (USTR) released its annual “Special 301 Report” today, which reviews countries based on their intellectual property (IP) rights protection and enforcement. Countries that are deemed by the U.S. to not protect IP strongly enough are placed on this watch list.

February 06, 2018

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) has filed a legal petition to the Supreme Court of South Korea requesting that the court review Pfizer’s patent to for its pneumococcal conjugate vaccine (PCV).

December 18, 2017

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) has filed a patent challenge in China to block Gilead’s patent application for the combination of two key oral hepatitis C medicines, sofosbuvir and velpatasvir.

November 20, 2017

Pfizer does not deserve the patent it was granted in August on its pneumonia vaccine Prevnar13 (PCV13), said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF). MSF is set to argue tomorrow in the High Court of Delhi that it should be overturned because the patent doesn’t meet the standards laid out in India’s Patents Act.

November 15, 2017

Ahead of the first-ever Global Ministerial Conference on “Ending TB” in Moscow, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF), the Stop TB Partnership, and tens of thousands of supporters called for countries with the most people affected by tuberculosis (TB) to implement the latest international treatment and testing standards by World TB Day, March 24, 2018.

November 14, 2017

Ministers from the eleven countries assessing the Trans-Pacific Partnership (TPP) trade deal have suspended many of the damaging provisions that would have restricted access to medicines and vaccines, a victory for millions of people who rely on affordable medicines worldwide.

October 31, 2017

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) announced today it can now purchase generic hepatitis C medicines for as low as $1.40 per day, or $120 per 12-week treatment course, for two key medicines used to treat and cure this disease, sofosbuvir and daclatasvir. This dramatic price reduction—which will benefit patients in countries where MSF can supply generic versions—illustrates the importance of generic options, which could, if expanded, help countries provide treatment for millions of people and improve public health by preventing the spread of this disease.

Pages